016 - Brexit: What You Need to Know for Drug Development

What We Covered 00:54 – Ed, Brian and Meranda welcome to the show Amber Sheriff who speaks to her background as a regulatory affairs specialist in the pharmaceutical industry and the three procedures for obtaining market authorization in the European Union 06:15 – What CMC drug development looks like in the EU and how it differs from the United States 11:24 – Amber breaks down specifics of the centralized filing procedure in the EU 15:49 – Amber provides insights on the impact of Brexit on CMC filing in the EU 18:40 – Benefits and advantages of a decentralized or mutual recognition procedure 23:28 – Amber speculates on the future of drug regulation, including collaborations between the FDA and the EU 27:57 – Finals thoughts from Amber 31:28 – Ed, Brian and Meranda thank Amber for joining the show Tweetable Quotes “In principle, there are three procedures for obtaining market authorization in EU. One is the mutual recognition procedure. The second one is the decentralized. And then the third one is the centralized procedure.” “If you get an approval in Europe, there are testings that you have to do for EU.” “Effective planning is the key. Because then basically you know when you’re going to get approval and you’ll know when you will be able to market.” “So, what is happening now, people who have filed in the UK can no longer sell their products in EU because UK walked away from the European Union. So now they are setting up their own procedures because, by the end of this year, they will be fully separated from the European Union.” “The mutual recognition that is between the FDA and EU, I see that as becoming more and more the norm.” “Once you get the approval [in the EU], you get it in all twenty-seven countries, including Norway, Iceland and I think Lithuania.” Relevant Links Design Space InPharmatics – LinkedIn Design Space InPharmatics – Twitter Edward Narke on LinkedIn Amber Sheriff on LinkedIn

You can listen to 016 - Brexit: What You Need to Know for Drug Development online on Radio and Podcast. Open the player on this page to stream the available audio.

016 - Brexit: What You Need to Know for Drug Development is an episode from CMC Live - Chemistry, Manufacturing & Controls by DSI.

This episode is 00:32:41 long.

This episode was published on Nov 20, 2020.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from CMC Live - Chemistry, Manufacturing & Controls when more episodes are available from the podcast feed.